#Cancerscreening

Leading medical professionals have developed evidence-based screening recommendations specifically targeting women born between 1990 and 1997, recognizing this demographic’s unique position at the intersection of evolving career expectations, delayed family planning decisions, and emerging health risks associated with modern urban lifestyles throughout Thailand and globally. These comprehensive assessment protocols acknowledge the significant demographic shifts occurring within Thai society, where increasing numbers of women pursue higher education and establish careers before considering marriage and childbearing, creating new health challenges that require proactive medical monitoring and preventive intervention strategies. The timing proves particularly crucial as this generation reaches ages where reproductive capacity begins natural decline while facing elevated risks for various chronic diseases that benefit from early detection and management through systematic screening approaches.

A recent wave of medical advice from global and regional experts is shining a spotlight on the critical health, reproductive, and fertility screenings that women born between 1990 and 1997 should prioritise. As more women delay motherhood and face evolving health risks associated with modern urban lifestyles, these check-ups have become increasingly vital, not just globally but for Thai women navigating similar trends in Bangkok and beyond. With rising awareness about female health and wellness, especially in reproductive years, Thai women now have an opportunity to assess and future-proof their well-being through timely, evidence-based medical screenings.

Amid rising cancer rates worldwide and particularly in Thailand, the latest expert guidance on reducing cancer risk—outlined by a leading oncologist in the Washington Post—reinforces a growing body of research linking lifestyle and preventive action to powerful protective effects. This advice, supported by studies that span continents, medical practices, and Thai experience, holds fresh relevance as innovative screening methods and vaccination programs evolve in the kingdom.

Cancer is one of the most burdensome diseases in Thailand, responsible for thousands of new cases and fatalities each year. Thailand’s National Cancer Institute notes that cancer was the leading cause of death in the nation for the past decade, claiming more than 80,000 lives annually (UICC). As medical strategies shift from treatment to prevention, Thai readers have the opportunity to benefit from a science-backed toolset—ranging from dietary tweaks and exercise to specific cancer screenings and vaccines—that dramatically cuts cancer risk.

Recent news of former US President Joseph Biden’s advanced prostate cancer has reignited global debate, including among Thai health professionals and men, about the value of prostate-specific antigen (PSA) blood tests for the early detection of prostate cancer. Prostate cancer, the most commonly diagnosed cancer among men in the United States and an important concern worldwide, presents a unique challenge: distinguishing aggressive, potentially deadly tumors from slow-growing ones that may never pose harm. This ongoing health debate holds particular significance for Thai men, as prostate cancer incidence in Thailand has gradually risen—mirroring trends in the West as life expectancy increases and populations age. Understanding the evolving research on PSA testing can help Thai families make informed decisions about their own health.

Recent renewed attention to prostate cancer and the PSA screening test, spurred by the diagnosis of former US President Joseph Biden, is once again igniting debate among health experts and patients worldwide — including in Thailand. Prostate cancer remains the most commonly diagnosed cancer among men in the United States and is a significant health concern for aging populations globally. The latest research and guidance show that the path forward for PSA (prostate-specific antigen) testing is both complicated and deeply personal, underscoring an urgent need for Thai men and their healthcare practitioners to weigh the pros and cons of screening within the context of current science and local realities.

A major new report brings much-needed relief to the global cancer community, revealing that advanced cancer diagnoses in the United States—which spiked during the early days of the COVID-19 pandemic—have now returned to levels seen before the global crisis. Published Monday in the journal Cancer, the study offers a broad analysis of U.S. cancer statistics, addressing widespread fears that disruptions to screening during the pandemic would drive a lasting increase in late-stage cancer cases and, ultimately, higher death rates (AP News).

A recent analysis published by The New York Times is offering renewed hope to millions concerned about cancer, highlighting that up to 40% of cancer cases in adults can be traced back to lifestyle factors that are within our control to change (NYT, 2025). This finding underscores the significant opportunity everyone—regardless of family history—has to shape their own cancer risk through choices about smoking, diet, body weight, and exercise. For Thai readers navigating personal or familial cancer anxieties, these insights could not be more timely.